Chemoinformaics analysis of 3-(2,2-DIMETHYLCHROMEN-6-YL)-7-HYDROXYCHROMEN-4-ONE
| Molecular Weight | 320.344 | nRot | 1 |
| Heavy Atom Molecular Weight | 304.216 | nRig | 6 |
| Exact Molecular Weight | 320.105 | nRing | 4 |
| Solubility: LogS | -0.844 | nHRing | 2 |
| Solubility: LogP | -0.136 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 17 |
| nHA | 4 | APOL | 47.2767 |
| nHD | 1 | BPOL | 20.3913 |
| QED | 0.372 |
| Synth | 4.1 |
| Natural Product Likeliness | 2.007 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.005 |
| HIA | 0.025 |
| CACO-2 | -4.623 |
| MDCK | 0.0000809 |
| BBB | 0.995 |
| PPB | 0.11313 |
| VDSS | 2.405 |
| FU | 0.766192 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.059 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.156 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.408 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.143 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.061 |
| CL | 2.577 |
| T12 | 0.662 |
| hERG | 0.023 |
| Ames | 0.287 |
| ROA | 0.764 |
| SkinSen | 0.915 |
| Carcinogencity | 0.622 |
| EI | 0.367 |
| Respiratory | 0.926 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.769094 |